"10.1371_journal.pone.0150621","plos one","2016-03-03T00:00:00Z","James A G Crispo; Allison W Willis; Dylan P Thibault; Yannick Fortin; Harlen D Hays; Douglas S McNair; Lise M Bjerre; Dafna E Kohen; Santiago Perez-Lloret; Donald R Mattison; Daniel Krewski","McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada; Fulbright Canada Student, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America; Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America; Cerner Corporation, Kansas City, Missouri, United States of America; C. T. Lamont Primary Health Care Research Centre, Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada; Bruy√®re Research Institute, Ottawa, Ontario, Canada; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada; Cardiology Research Institute, University of Buenos Aires, National Research Council (ININCA-UBA-CONICET), Buenos Aires, Argentina; Risk Sciences International, Ottawa, Ontario, Canada","Conceived and designed the experiments: JAGC AWW LMB DEK DRM DK. Performed the experiments: JAGC DPT YF. Analyzed the data: JAGC AWW DPT YF HDH DSM LMB DEK SPL DRM DK. Wrote the paper: JAGC AWW. Edited the manuscript: JAGC AWW DPT YF HDH DSM LMB DEK SPL DRM DK.","Mr. Crispo, Dr. Willis, Mr. Thibault, Mr. Fortin, Dr. Bjerre, and Dr. Kohen report no disclosures. Dr. McNair and Mr. Hays are employed by the Cerner Corporation. Dr. Perez-Lloret served as a consultant for Aguettant Laboratories in 2014. Drs. Mattison and Krewski serve as Chief Medical Officer and Chief Risk Scientist of Risk Sciences International, a Canadian company formed in partnership with the University of Ottawa in 2006 (www.risksciences.com) that conducts risk assessment work for public and private sector clients in Canada and internationally. To date, RSI has not conducted work on the subject of the present research paper. Dr. Krewski holds a Natural Sciences and Engineering Council of Canada (NSERC) Industrial Research Chair in Risk Science, through a peer-reviewed university-industry partnerships program administered by NSERC. None of the industrial partners in this program are from the pharmaceutical industry. Commercial affiliation with the Cerner Corporation and Risk Sciences International does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","03","James A G Crispo","JAGC",11,TRUE,6,3,11,2,TRUE,TRUE,FALSE,0,NA,FALSE
